The Role of MicroRNA-146a in the Pathogenesis of the Diabetic Wound-Healing Impairment

The impairment in diabetic wound healing represents a significant clinical problem. Chronic inflammation is thought to play a central role in the pathogenesis of this impairment. We have previously shown that treatment of diabetic murine wounds with mesenchymal stem cells (MSCs) can improve healing, but the mechanisms are not completely defined. MicroRNA-146a (miR-146a) has been implicated in regulation of the immune and inflammatory responses. We hypothesized that abnormal miRNA-146a expression may contribute to the chronic inflammation. To test this hypothesis, we examined the expression of miRNA-146a and its target genes in diabetic and nondiabetic mice at baseline and after injury. MiR-146a expression was significantly downregulated in diabetic mouse wounds. Decreased miR-146a levels also closely correlated with increased gene expression of its proinflammatory target genes. Furthermore, the correction of the diabetic wound-healing impairment with MSC treatment was associated with a significant increase in the miR-146a expression level and decreased gene expression of its proinflammatory target genes. These results provide the first evidence that decreased expression of miR-146a in diabetic wounds in response to injury may, in part, be responsible for the abnormal inflammatory response seen in diabetic wounds and may contribute to wound-healing impairment.

[1]  Paul G Scott,et al.  Mesenchymal Stem Cells Enhance Wound Healing Through Differentiation and Angiogenesis , 2007, Stem cells.

[2]  A. Boulton,et al.  Transforming growth factor‐beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[3]  Lindolfo da Silva Meirelles,et al.  Mesenchymal stem cells reside in virtually all post-natal organs and tissues , 2006, Journal of Cell Science.

[4]  A. Cerami,et al.  Cloning and characterization of cDNAs for murine macrophage inflammatory protein 2 and its human homologues , 1990, The Journal of experimental medicine.

[5]  George M. Wahba,et al.  Intervertebral Disc Cell Therapy for Regeneration: Mesenchymal Stem Cell Implantation in Rat Intervertebral Discs , 2004, Annals of Biomedical Engineering.

[6]  Andrea T. Badillo,et al.  Enhanced epithelial gap closure and increased angiogenesis in wounds of diabetic mice treated with adult murine bone marrow stromal progenitor cells , 2007, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[7]  D. Baltimore,et al.  NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.

[8]  J. Pfeilschifter,et al.  Wound Healing in Mice with High-Fat Diet- or ob Gene-Induced Diabetes-Obesity Syndromes: A Comparative Study , 2011, Experimental diabetes research.

[9]  D. Greenhalgh,et al.  Cutaneous Wound Healing , 2007, Journal of burn care & research : official publication of the American Burn Association.

[10]  Gordon J. Lithgow,et al.  MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8 , 2009, Aging.

[11]  Keiichiro Nishida,et al.  Expression of microRNA-146 in rheumatoid arthritis synovial tissue. , 2008, Arthritis and rheumatism.

[12]  E. Jude,et al.  The molecular biology of chronic wounds and delayed healing in diabetes , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[13]  J. Gorman,et al.  Regenerative healing following foetal myocardial infarction. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[14]  Andrea T. Badillo,et al.  Lentiviral Gene Transfer of SDF-1α to Wounds Improves Diabetic Wound Healing , 2007 .

[15]  Andrea T. Badillo,et al.  Treatment of diabetic wounds with fetal murine mesenchymal stromal cells enhances wound closure , 2007, Cell and Tissue Research.

[16]  K. Ward,et al.  Correlation of tear inflammatory cytokines and matrix metalloproteinases with four dry eye diagnostic tests. , 2012, Investigative ophthalmology & visual science.

[17]  F. Dietrich,et al.  Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs , 2006, Nature Genetics.

[18]  P. Linsley,et al.  miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice , 2011, The Journal of experimental medicine.

[19]  H. Shimizu,et al.  Mesenchymal Stem Cells Are Recruited into Wounded Skin and Contribute to Wound Repair by Transdifferentiation into Multiple Skin Cell Type1 , 2008, The Journal of Immunology.

[20]  K. Liechty,et al.  Inhibition of stromal cell-derived factor-1α further impairs diabetic wound healing. , 2011, Journal of vascular surgery.

[21]  H. Koo,et al.  Gene expression profile of cytokine and growth factor during differentiation of bone marrow-derived mesenchymal stem cell. , 2005, Cytokine.

[22]  P. Tak,et al.  MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. , 2009, Arthritis and rheumatism.

[23]  Elaine Fuchs,et al.  A skin microRNA promotes differentiation by repressing ‘stemness’ , 2008, Nature.

[24]  김명희.  Hypoxia-enhanced wound-healing function of adipose-derived stem cells: increase in stem cell proliferation and up-regulation of VEGF and Bfgf , 2009 .

[25]  T. Fahey,et al.  Diabetes impairs the late inflammatory response to wound healing. , 1991, The Journal of surgical research.

[26]  J. Park,et al.  Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. , 2007, Journal of dermatological science.

[27]  Vishal Kapoor,et al.  Contribution of Bone Marrow–Derived Cells to Skin: Collagen Deposition and Wound Repair , 2004, Stem cells.

[28]  Andrea T. Badillo,et al.  Lentiviral gene transfer of SDF-1alpha to wounds improves diabetic wound healing. , 2007, The Journal of surgical research.

[29]  V. Falanga,et al.  Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. , 2007, Tissue engineering.

[30]  Lisa Scott.  Diabetic foot ulcers. , 2013, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[31]  P. Janson,et al.  MicroRNAs: Novel Regulators Involved in the Pathogenesis of Psoriasis? , 2007, PloS one.

[32]  D. Sane,et al.  Abnormal angiogenesis in diabetes mellitus , 2003, Medicinal research reviews.

[33]  T. Salo,et al.  Human mesenchymal stem cell derived osteoblasts degrade organic bone matrix in vitro by matrix metalloproteinases. , 2005, Matrix biology : journal of the International Society for Matrix Biology.

[34]  F. Barry.  Biology and clinical applications of mesenchymal stem cells. , 2003, Birth defects research. Part C, Embryo today : reviews.

[35]  J. Pfeilschifter,et al.  Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. , 2000, The Journal of investigative dermatology.

[36]  W. Filipowicz,et al.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.

[37]  Evan S Snitkin,et al.  Longitudinal shift in diabetic wound microbiota correlates with prolonged skin defense response , 2010, Proceedings of the National Academy of Sciences.

[38]  L. O’Neill,et al.  Adding fuel to fire: microRNAs as a new class of mediators of inflammation , 2008, Annals of the rheumatic diseases.

[39]  Liwen Chen,et al.  Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound Healing , 2008, PloS one.